COMPARING THE EFFICACY OF CEFTAZIDIME AND MEROPENEM IN TREATMENT OF FEBRILE NEUTROPENIA IN PEDIATRIC PATIENTS WITH CANCER

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

FERDOSIAN F.; GHILIYAN R.; HASHEMI A.; AKHONDZADEH B.; GHOLAMPOOR E.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY Year:2013 | Volume:3 | Issue:3 Page(s): 103-107

Download Full-Text

View:

354

Download:

100

Cites:

Information Journal Paper

Title

COMPARING THE EFFICACY OF CEFTAZIDIME AND MEROPENEM IN TREATMENT OF FEBRILE NEUTROPENIA IN PEDIATRIC PATIENTS WITH CANCER

Author(s)

Keywords

CEFTAZIDIME

MEROPENEM

PEDIATRICS

Abstract

Background: In cancer patients, various infections were developed due to severe neutropenia resulted from chemotherapy. CEFTAZIDIME is commonly used as monotherapy of cancer patients with fever and neutropenia. MEROPENEM is a new carbapenem with more extended antibacterial spectrum including anaerobes. It provides better coverage against gram positives. This trial compared the efficacy and safety of MEROPENEM with CEFTAZIDIME as empirical monotherapy for febrile neutropenia in pediatric patients with cancer.Materials and Methods: A prospective, double-blind, randomized clinical trial was conducted at Departments of Pediatric Haematology/Oncology, University Hospitals, Yazd, Iran, during the years 2012 to 2013. A total of 48 cancer patients participated in the trial.Result: In this study, 26 patients (54.16%) were treated by CEFTAZIDIME and 22 patients (45.84%) by MEROPENEM. Mean duration of fever in those who responded to treatment in CEFTAZIDIME group was 19.43+/-31.04 hours, and in MEROPENEM group was 16.53+/-28.77 hours (P-value=0.965). Conclusion: Finding of this study indicate that CEFTAZIDIME and MEROPENEM have similar efficacy in treatment of fever and sever neutropenia. Due to more availability and lower cost of CEFTAZIDIME than MEROPENEM, CEFTAZIDIME is suggested as a first line treatment in fever and neutropenia.

Cites

No record.

References

No record.

Cite

APA: Copy

FERDOSIAN, F., GHILIYAN, R., HASHEMI, A., AKHONDZADEH, B., & GHOLAMPOOR, E.. (2013). COMPARING THE EFFICACY OF CEFTAZIDIME AND MEROPENEM IN TREATMENT OF FEBRILE NEUTROPENIA IN PEDIATRIC PATIENTS WITH CANCER. IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, 3(3), 103-107. SID. https://sid.ir/paper/320628/en

Vancouver: Copy

FERDOSIAN F., GHILIYAN R., HASHEMI A., AKHONDZADEH B., GHOLAMPOOR E.. COMPARING THE EFFICACY OF CEFTAZIDIME AND MEROPENEM IN TREATMENT OF FEBRILE NEUTROPENIA IN PEDIATRIC PATIENTS WITH CANCER. IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY[Internet]. 2013;3(3):103-107. Available from: https://sid.ir/paper/320628/en

IEEE: Copy

F. FERDOSIAN, R. GHILIYAN, A. HASHEMI, B. AKHONDZADEH, and E. GHOLAMPOOR, “COMPARING THE EFFICACY OF CEFTAZIDIME AND MEROPENEM IN TREATMENT OF FEBRILE NEUTROPENIA IN PEDIATRIC PATIENTS WITH CANCER,” IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, vol. 3, no. 3, pp. 103–107, 2013, [Online]. Available: https://sid.ir/paper/320628/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops